NBC News, CNN: Company reports Alzheimer's drug study data
September 28, 2022
The University of Cincinnati's Alberto Espay, MD, was featured in an NBC News article reporting on results from a phase three Alzheimer's drug trial.
September 28, 2022
The University of Cincinnati's Alberto Espay, MD, was featured in an NBC News article reporting on results from a phase three Alzheimer's drug trial.
October 6, 2022
Researchers at the University of Cincinnati are leading the CAPSTONE study that will learn more about how inflammation affects patient recovery after intracerebral hemorrhage strokes.
October 25, 2022
National media outlets highlighted the results of the first-in-human trial of FLASH radiotherapy, led by University of Cincinnati Cancer Center researchers.
December 5, 2022
University of Cincinnati researchers have published a new study examining factors behind the decision to begin or decline medication treatment for childhood anxiety disorders after cognitive behavioral therapy did not lead to improvement.
December 8, 2022
Physics World recognized the University of Cincinnati's first-in-human trial of FLASH radiotherapy as one of the Top 10 Breakthroughs of the Year for 2022.
March 3, 2023
Healio highlighted research from the University of Cincinnati and Cincinnati Children's Hospital Medical Center's Christa Krupski that found a second round of tisa-cel CAR-T treatment for young patients with acute lymphoblastic leukemia led to few clinically meaningful responses.
February 27, 2023
The University of Cincinnati's Pooja Khatri joined Local 12's What's Happening in Health to discuss advancements in stroke research.
March 9, 2023
KYTV News in Springfield, Missouri highlighted the University of Cincinnati's epilepsy transition clinic that helps guide patients as they move from pediatric to adult care.
March 17, 2023
Aunt Minnie highlighted University of Cincinnati research that found a radiology-oriented transgender curriculum showed success in increasing radiologists' awareness about transgender patients.
March 21, 2023
Amanda Jackson, MD, is the site principal investigator at the University of Cincinnati for the UP-NEXT trial that is testing a new treatment for a subset of ovarian cancer patients.